Delivery Order SPE2DB25D3012-SPE2DB25FWYPV
Award Date 7/14/25
Potential Completion Date 8/4/25
Potential Value $8.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,687.44 to AmerisourceBergen Drug Corp for PROQUAD vials on October 22, 2025, with completion targeted for November 13, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at the...
- The Defense Logistics Agency's Medical Supply Chain awarded a $16.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of October 14, 2025. This competitive award, issued on September 22, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency awarded a delivery order valued at $9,274.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed competitively. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with a completion date of September 26, 2025. This is a firm fixed-price contract awarded competitively without a set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger vehicle, this delivery order leverages AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,308.68 to AmerisourceBergen Drug Corp on June 4, 2025, for PROQUAD vials with an ultimate completion date of June 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine product, and this order represents a routine pharmaceutical supply transaction within the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROQUAD vials valued at $5,426.96 under a firm fixed price contract structure. This non-set-aside award, announced on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is being fulfilled from the company's Conshohocken, Pennsylvania facility, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROQUAD vials valued at $4,813.98 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by December 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,269.24 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of July 22, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PROQUAD is a combination vaccine used to prevent measles, mumps, rubella, and varicella, representing part of the...
- The Defense Logistics Agency awarded a $8,023.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of December 24, 2025. This is a competitively awarded, non-set-aside contract that serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is the vendor's corporate office location in...